Results From a Human Renal Allograft Tolerance Trial Evaluating the Humanized Cd52-specific Monoclonal Antibody Alemtuzumab (campath-1h)
Year: 2003
Type: article
Source: Transplantation
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2010606148
